Slater-MacLean Linda, Cembrowski George, Chin Dat, Shalapay Carol, Binette Tanya, Hegadoren Kathy, Newburn-Cook Christine
Critical Care Initiatives, Inc, University of Alberta Hospital, Edmonton, Alberta, Canada.
Diabetes Technol Ther. 2008 Jun;10(3):169-77. doi: 10.1089/dia.2008.0263.
Recent evidence emphasizes the importance of maintaining normoglycemia in critically ill patients to reduce morbidity and mortality. Different analytical methods of varying accuracy exist for obtaining and measuring blood glucose in critically ill patients. The purpose of this study was to determine if there were differences in blood glucose values measured by whole blood capillary and arterial samples using three different bedside blood glucose meters and a blood gas analyzer as compared to a reference blood glucose analyzer.
Sixty subjects were recruited from a university hospital medical/surgical intensive care unit. Matching capillary and arterial samples were analyzed by a clinical blood glucose reference analyzer (YSI, Yellow Springs Instrument, Yellow Springs, OH) and three blood glucose meters (Lifescan [Milpitas, CA] SureStepFlexx, Roche [Indianapolis, IN] Accu-Chek Inform, and Abbott [Alameda, CA] FreeStyle). Additionally, the arterial samples were analyzed by a point-of-care blood gas analyzer (Chiron 865, Bayer, Tarrytown, NY).
Data analysis included repeated-measures analysis of variance, Consensus Error Grid analysis, Bland-Altman plots, and numerical estimates of inaccuracy. With capillary samples there were high numbers of errors as compared to the reference instrument. Measurement of blood glucose with arterial samples demonstrates a higher degree of accuracy. With arterial samples, the Abbott FreeStyle blood glucose meter and the blood gas analyzer glucose exhibited the lowest median and mean relative absolute deviation.
In critically ill adult patients, measurement of blood glucose using arterial samples is recommended. Using arterial blood, the Abbott FreeStyle blood glucose meter and the point-of-care blood gas analyzer (Bayer Chiron 865) were shown to be highly accurate instruments to measure arterial blood glucose.
近期证据强调了维持危重症患者正常血糖水平以降低发病率和死亡率的重要性。在危重症患者中,存在不同准确性的多种分析方法用于获取和测量血糖。本研究的目的是确定与参考血糖仪相比,使用三种不同的床边血糖仪和一台血气分析仪对全血毛细血管和动脉样本进行血糖测量时,血糖值是否存在差异。
从一所大学医院的内科/外科重症监护病房招募了60名受试者。配对的毛细血管和动脉样本由临床血糖参考分析仪(YSI,黄泉仪器公司,俄亥俄州黄泉市)和三台血糖仪(强生 [加利福尼亚州米尔皮塔斯] SureStepFlexx、罗氏 [印第安纳州印第安纳波利斯] 卓越型血糖仪、雅培 [加利福尼亚州阿拉米达] 稳豪血糖仪)进行分析。此外,动脉样本由一台即时检验血气分析仪(拜耳Chiron 865,纽约州塔里敦)进行分析。
数据分析包括重复测量方差分析、一致性误差网格分析、Bland-Altman图以及不准确性的数值估计。与参考仪器相比,毛细血管样本存在大量误差。动脉样本的血糖测量显示出更高的准确度。对于动脉样本,雅培稳豪血糖仪和血气分析仪的血糖测量结果的中位数和平均相对绝对偏差最低。
对于危重症成年患者,建议使用动脉样本测量血糖。使用动脉血时,雅培稳豪血糖仪和即时检验血气分析仪(拜耳Chiron 865)被证明是测量动脉血糖的高度准确的仪器。